Medicare

Medicare premiums to remain unchanged after Aduhelm price cut spurs review
BioPharma Dive
Tue, 05/31/22 - 11:56 pm
Medicare
Medicare Part B
Biogen
Aduhelm
HHS
Alzheimer's disease
Drug plan prices touted during Medicare open enrollment can rise within a month
NPR
Tue, 05/3/22 - 10:38 am
Medicare
drug pricing
The next battle in the never-ending war over Aduhelm
Stat
Fri, 04/15/22 - 01:50 pm
Biogen
Aduhelm
Medicare
CMS
Eli Lilly
Alzheimer's disease
CMS official on Alzheimer's drug coverage decision: Don't read between the lines for other accelerated approvals
Endpoints
Wed, 04/13/22 - 10:54 am
CMS
Medicare
Biogen
Aduhelm
accelerated approvals
How CMS independence is at the forefront of its Alzheimer's drug coverage decision
Endpoints
Mon, 04/11/22 - 10:34 am
CMS
Medicare
Biogen
Aduhelm
Alzheimer's disease
With Aduhelm slapped down by CMS, what's next for Biogen?
Fierce Pharma
Fri, 04/8/22 - 10:29 am
Biogen
Aduhelm
Medicare
Alzheimer's disease
Many Medicare patients don't fill prescriptions for specialty drugs, study finds
Beckers Hospital Review
Fri, 04/8/22 - 10:26 am
Medicare
Medicare Part D
specialty drugs
CMS finalizes restrictions on Biogen's Alzheimer's drug coverage, will only fund use in clinical trials
Endpoints
Thu, 04/7/22 - 06:13 pm
Biogen
Aduhelm
CMS
Alzheimer's disease
clinical trials
Medicare
More biosimilar use could've saved Medicare and beneficiaries $84M in 2019, HHS OIG says
Endpoints
Sat, 04/2/22 - 11:46 am
biosimilars
Medicare
CMS
Medicare Part D
Three big Congressional hearings next week to set the tenor on Covid-19, drug prices, and ARPA-H
Endpoints
Thu, 03/10/22 - 10:26 pm
congress
COVID-19
drug pricing
Medicare
ARPA-H
GSK joins a crowd of pharma companies restricting sales under federal program
Endpoints
Mon, 02/14/22 - 11:41 pm
GSK
340B
Medicare
Medicaid
CBO: Medicare negotiations will hamper drug development more than previously thought
Endpoints
Tue, 01/18/22 - 10:36 am
drug development
CBO
Medicare
With its Aduhelm proposal, Medicare is stepping into a heated debate about how best to improve equity in Alzheimer’s treatment
Stat
Fri, 01/14/22 - 10:56 am
Medicare
Aduhelm
Biogen
CMS
racial disparity
Alzheimer's disease
Biogen leaders warn sales teams: Only 2,000 patients might access Aduhelm over the next several years
Endpoints
Thu, 01/13/22 - 10:26 pm
Biogen
Aduhelm
CMS
drug reps
Medicare
Alzheimer's disease
For Biogen's Aduhelm, narrow coverage from CMS 'could effectively spell the end': analyst
Fierce Pharma
Wed, 01/12/22 - 11:01 am
CMS
Biogen
Aduhelm
Medicare
clinical trials
Alzheimer's disease
Medicare proposes to limit coverage of Biogen Alzheimer's drug
BioPharma Dive
Tue, 01/11/22 - 10:22 pm
Biogen
Aduhelm
CMS
Medicare
Biogen's Aduhelm faces a key coverage decision next week. Which way will Medicare rule, and how much does it matter?
Fierce Pharma
Thu, 01/6/22 - 12:59 pm
Biogen
Aduhelm
Medicare
CMS
Alzheimer's disease
Biden touts drug cost measures in spending bill
Beckers Hospital Review
Tue, 12/7/21 - 11:44 pm
Joe Biden
Build Back Better Act
drug pricing
insulin
Medicare
Exclusive accelerated approval drugs comprise ‘relatively small share’ of Medicare spending
RAPS.org
Mon, 12/6/21 - 11:44 pm
regulatory
accelerated approvals
Medicare
Congress passes on delay to Medicare rate cuts for lab tests, for now
Medtech Dive
Mon, 12/6/21 - 10:40 am
Medicare
diagnostics
legislation

Pages